HYPERTENSION, THE ENDOTHELIAL-CELL, AND THE VASCULAR COMPLICATIONS OF DIABETES-MELLITUS

被引:113
作者
HSUEH, WA [1 ]
ANDERSON, PW [1 ]
机构
[1] UNIV SO CALIF,MED CTR,LOS ANGELES,CA 90089
关键词
DIABETES-MELLITUS; ENDOTHELIUM; VASCULAR; HYPERTENSION; ESSENTIAL;
D O I
10.1161/01.HYP.20.2.253
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hypertension is a major factor that contributes to the development of the vascular complications of diabetes mellitus, which primarily include atherosclerosis, nephropathy, and retinopathy. The mechanism of the pathophysiological effects of hypertension lies at the cellular level in the blood vessel wall, which intimately involves the function and interaction of the endothelial and vascular smooth muscle cells. Both hypertension and diabetes mellitus alter endothelial cell structure and function. In large and medium size vessels and in the kidney, endothelial dysfunction leads to enhanced growth and vasoconstriction of vascular smooth muscle cells and mesangial cells, respectively. These changes in the cells of smooth muscle lineage play a key role in the development of both atherosclerosis and glomerulosclerosis. In diabetic retinopathy, damage and altered growth of retinal capillary endothelial cells is the major pathophysiological insult leading to proliferative lesions of the retina. Thus, the endothelium emerges as a key target organ of damage in diabetes mellitus; this damage is enhanced in the presence of hypertension. An overall approach to the understanding and treatment of diabetes mellitus and its complications will be to elucidate the mechanisms of vascular disease and endothelial cell dysfunction that occur in the setting of hypertension and diabetes.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 133 条
[91]  
PORTA M, 1990, ENDOTHELIAL CELL FUN, V9, P156
[93]   INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME PREVENT MYOINTIMAL PROLIFERATION AFTER VASCULAR INJURY [J].
POWELL, JS ;
CLOZEL, JP ;
MULLER, RKM ;
KUHN, H ;
HEFTI, F ;
HOSANG, M ;
BAUMGARTNER, HR .
SCIENCE, 1989, 245 (4914) :186-188
[94]  
Pyorala K, 1979, Diabetes Care, V2, P131, DOI 10.2337/diacare.2.2.131
[95]  
PYORALA K, 1985, ACTA MED SCAND S, V701, P38
[96]   NON-INSULIN-DEPENDENT DIABETES-MELLITUS, ABNORMAL LIPOPROTEIN METABOLISM, AND ATHEROSCLEROSIS [J].
REAVEN, GM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (02) :1-8
[97]  
REAVEN GM, 1987, LANCET, V2, P435
[98]   ENALAPRIL IMPROVES ALBUMINURIA BY PREVENTING GLOMERULAR LOSS OF HEPARAN-SULFATE IN DIABETIC RATS [J].
REDDI, AS ;
RAMAMURTHI, R ;
MILLER, M ;
DHUPER, S ;
LASKER, N .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1991, 45 (01) :119-131
[99]   EFFECT OF WEIGHT-LOSS WITHOUT SALT RESTRICTION ON REDUCTION OF BLOOD-PRESSURE IN OVERWEIGHT HYPERTENSIVE PATIENTS [J].
REISIN, E ;
ABEL, R ;
MODAN, M ;
SILVERBERG, DS ;
ELIAHOU, HE ;
MODAN, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (01) :1-6
[100]   INSULIN AND RENAL SODIUM RETENTION IN OBESE ADOLESCENTS [J].
ROCCHINI, AP ;
KATCH, V ;
KVESELIS, D ;
MOOREHEAD, C ;
MARTIN, M ;
LAMPMAN, R ;
GREGORY, M .
HYPERTENSION, 1989, 14 (04) :367-374